Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis - Concepedia

Concepedia

Publication | Open Access

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

DOI Full Paper Access

628

Citations

23

References

2007

Year

Peter G. Pappas, C. M. F. Rotstein, Robert F. Betts, Márcio Nucci, Deepak Talwar, Jan J. De Waele, José A. Vázquez, B Dupont, David L. Horn, Luis Ostrosky‐Zeichner,

Clinical Infectious Diseases

Abstract

Dosages of micafungin 100 mg daily and 150 mg daily were noninferior to a standard dosage of caspofungin for the treatment of candidemia and other forms of invasive candidiasis.

References

	Year	Citations
A sharper Bonferroni procedure for multiple tests of significance Yosef Hochberg Biometrika Israel SearchDecember 1988Multiple TestsQuantitative MethodsStatistical Review	1988	4.7K
Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study Hilmar Wisplinghoff, Thomas Bischoff, Sandra Tallent, Clinical Infectious Diseases	2004	4.5K
Guidelines for Treatment of Candidiasis Peter G. Pappas, John Rex, Jack D. Sobel, Clinical Infectious Diseases	2004	1.4K
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis Jorge Mora-Duarte, Robert F. Betts, Coleman Rotstein, New England Journal of Medicine	2002	1.4K
Attributable Mortality of Nosocomial Candidemia, Revisited Stephen H. Gillespie, Kyungwon Lee, Jeffery Vande Berg, Clinical Infectious Diseases	2003	1.1K
A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia John Rex, John E. Bennett, Alan M. Sugar, New England Journal of Medicine	1994	1K
Anidulafungin versus Fluconazole for Invasive Candidiasis Annette C. Reboli, Coleman Rotstein, Peter G. Pappas, New England Journal of Medicine	2007	888
A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients Peter G. Pappas, John Rex, J. Lee, Clinical Infectious Diseases	2003	849
The Epidemiology and Attributable Outcomes of Candidemia in Adults and Children Hospitalized in the United States: A Propensity Analysis Theoklis E. Zaoutis, Jesse Argon, Junhao Chu, Clinical Infectious Diseases	2005	782
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial Ernst-Rüdiger Kuse, Ploenchan Chetchotisakd, Clóvis Arns da Cunha, The Lancet Invasive CandidosisAntifungal AgentAntifungal AgentsMedicinePhase Iii	2007	689

Page 1